Bovine serum albumin and Analytical Chemistry (journal) is closely connected to Chromatography in his research, which is encompassed under the umbrella topic of Detection limit. As part of his studies on Bovine serum albumin, Youn H. Kim often connects relevant subjects like Chromatography. In his study, he carries out multidisciplinary Analytical Chemistry (journal) and Spectroscopy research. He combines Spectroscopy and Detection limit in his research. He combines Genetics and Cancer research in his research. While working on this project, he studies both Cancer research and Cancer. He performs multidisciplinary study in Cancer and Cancer stem cell in his work. Youn H. Kim integrates Cancer stem cell and Cancer cell in his research. Youn H. Kim combines Cancer cell and Gene in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze.
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
Elise A. Olsen;Youn H. Kim;Timothy M. Kuzel;Theresa R. Pacheco.
Journal of Clinical Oncology (2007)
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
Elise Olsen;Madeleine Duvic;Arthur Frankel;Youn Kim.
Journal of Clinical Oncology (2001)
Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome: Clinical Prognostic Factors and Risk for Disease Progression
Youn H. Kim;Howard L. Liu;Serena Mraz-Gernhard;Anna Varghese.
Archives of Dermatology (2003)
Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
Sean J. Whittaker;Marie-France Demierre;Ellen J. Kim;Alain H. Rook.
Journal of Clinical Oncology (2010)
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic.
Journal of Clinical Oncology (2011)
Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma
Madeleine Duvic;Ann G. Martin;Youn Kim;Elise Olsen.
Archives of Dermatology (2001)
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)
Youn H. Kim;Rein Willemze;Nicola Pimpinelli;Sean Whittaker.
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
Nancy J. Senff;Evert M. Noordijk;Youn H. Kim;Martine Bagot.
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody;Weiyun Z. Ai;Debra K. Czerwinski;James A. Torchia.
Journal of Clinical Oncology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: